TB-500 (Thymosin β4 fragment)

TB-500 Molecular Weight, and the Figure That Is Wrong

UKPWritten & reviewed by William Heath · Editor, UK Peptides research library2 min readLast reviewed 2026-08-233 cited sources

The short answer

TB-500 as normally supplied is 889.0 Da. The figure of approximately 4.9 kDa, repeated across much of the internet and previously on this site, is the mass of full-length thymosin beta-4 at 4,963 Da. Using it for heptapeptide material overstates mass 5.6-fold.

Key facts

TB-500 (Ac-LKKTETQ)
889.0 Da, C38H68N10O14, CID 62707662
LKKTETQ (unmodified)
847.0 Da, C36H66N10O13, CID 10169788
Difference
42.0 Da = one acetyl group
Thymosin beta-4
4,963 Da, C212H350N56O78S, CID 16132341
Ratio of error
5.6-fold
Consequence
Molarity out by the same factor

The arithmetic that identifies the compound

Three masses are relevant and they interlock. Unmodified LKKTETQ is 847.0 Da. TB-500 is 889.0 Da. The difference is 42.0, which is the mass of an acetyl group added to the N-terminal amine. Full-length thymosin beta-4 is 4,963 Da, more than five times either. The heptapeptide numbers reconcile with each other; 4.9 kDa does not belong in that set at all.

Why the wrong figure propagated

TB-500 is described everywhere as a fragment of thymosin beta-4, and the parent protein's molecular weight is easy to find. Attaching the parent's mass to the fragment is a small step, and once made it is copied. Nothing in the resulting text looks wrong. The compound name is right, the parent is right, and only the number is transposed from one to the other.

Research material referenced

TB-500 5mg, third-party HPLC tested

Buy TB-500 · £23.99

What it costs in practice

Molarity is mass divided by molecular weight. Using 4,963 where the true value is 889 makes a solution 5.6 times more concentrated in molar terms than calculated. Any experiment specifying a molar concentration, any comparison against a published EC50, any dose-response relationship built on that arithmetic is wrong by that factor, and would not look obviously wrong at any point.

How to establish which you have

Mass spectrometry settles it immediately: 889 and 4,963 are not confusable. A certificate of analysis should state the molecular weight and the sequence, and if it states 43 residues or a mass near 4.9 kDa, the material is full-length thymosin beta-4 whatever the label says. If it states LKKTETQ or a mass near 889, it is the heptapeptide.

Why both products legitimately exist

Neither is a counterfeit. Full-length thymosin beta-4 is the protein most of the wound-repair and cardiac literature actually used. The heptapeptide is the actin-binding motif, cheaper to synthesise and the form most commonly sold as TB-500. Both are real compounds with real literatures; the problem is exclusively that one name is used for both.

Quick reference

CompoundFormulaMWPubChem CID
TB-500 (Ac-LKKTETQ)C38H68N10O14889.062707662
LKKTETQ (free)C36H66N10O13847.010169788
Thymosin beta-4C212H350N56O78S4,96316132341

Frequently asked questions

Is TB-500 889 Da or 4.9 kDa?

889.0 Da for the acetylated heptapeptide normally supplied. 4,963 Da is full-length thymosin beta-4, a different compound.

What is the 42 Da difference?

One acetyl group on the N-terminal amine. Unmodified LKKTETQ is 847.0; acetylated it is 889.0.

How do I check which I have?

Mass spectrometry, or a certificate stating sequence and mass. 889 and 4,963 are not confusable on any instrument.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

Browse the wider literature

Live database searches, not fixed citations. Results change as new work is indexed.

UKP

Written and reviewed by

William Heath · Editor, UK Peptides research library

William Heath edits the UK Peptides research library. He is responsible for what is published here: every article is sourced to primary literature, every purity or identity statement traces to a signed third-party certificate for a specific lot, and corrections are made in place with the review date updated. No scientific or medical credentials are claimed on this site; the evidence is carried by the cited sources and the certificates, not by the byline.

More TB-500 (Thymosin β4 fragment) articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.